Loading organizations...
Key people at Norwich Ventures.
Norwich Ventures was founded in 2004 by Aaron Sandoski (Co-Founder and Managing Director) and Marlin Miller (Co-founder and Senior Advisor).
Norwich Ventures operates as a specialized venture capital firm, focusing investments on early-stage medical technology companies. The firm provides initial capital to entrepreneurs developing innovative technologies addressing significant unmet medical needs. Investment strategy prioritizes best-in-class technology, capital efficiency, and a clear path to proof of concept.
Established in 2004, Norwich Ventures was co-founded by Aaron Sandoski and Marlin Miller, with Philip Fleck also foundational. The firm emerged from a shared recognition of the necessity for new medical technologies to solve complex healthcare challenges. This insight propelled their mission to create a platform dedicated to nurturing promising early-stage medtech enterprises.
Norwich Ventures primarily serves entrepreneurs and emerging companies within the medical technology sector. The firm's long-term vision is to accelerate groundbreaking medical innovations that enhance patient outcomes and transform healthcare. They maintain an agnostic approach to medical fields, seeking opportunities where new technologies offer substantial clinical value.
Key people at Norwich Ventures.
Norwich Ventures was founded in 2004 by Aaron Sandoski (Co-Founder and Managing Director) and Marlin Miller (Co-founder and Senior Advisor).
Norwich Ventures has 6 tracked investments across 4 companies. The latest tracked deal is $18.0M Series B in Ionpath in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2020 | Ionpath | $18.0M Series B | Samsara BioCapital | Endeavor Venture Funds, Genoa Ventures, Illumina Ventures, Paladin Capital Group, Rohan Thakur, NanoDimension, Paladin Partners Investments, Trancos IONpath Investors, Vertical Venture Partners |
| Aug 19, 2020 | Podimetrics | $2.6M Series B | — | Polaris Partners, Rock Health, Scientific Health Development |
| May 9, 2019 | Podimetrics | $13.4M Series B | — | Jeff Trost, Scientific Health Development |
| Mar 1, 2016 | Arterys | $5.0M Series A | Emergent Medical Partners | Asset Management Ventures, Great Oaks Venture Capital, AME Cloud Ventures, Asset Management Ventures (amv), GE Ventures, Morado Ventures, Stanford |
| Mar 2, 2015 | Daktari Diagnostics | $15.5M Series D | Eastern Capital, Merck | Partners Group |
| Dec 30, 2011 | Daktari Diagnostics | $10.0M Other Equity | Merck | Partners Innovation Fund |
